Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I B Duncan

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal (Canadian Dental Association)|December 1, 1982
The implications of viral hepatitis for the practice of dentistryJ H Main, I B Duncan, M M Fisher, et al.
Journal of Clinical Microbiology|December 1, 1978
Comparison of bacteriophage typing, serotyping, and biotyping as aids in epidemiological surveillance of Klebsiella infectionsR P Rennie, C E Nord, L Sjoberg, et al.
Journal of Clinical Microbiology|August 1, 1976
Preparation of typing antisera specific for O antigens of Pseudomonas aeruginosaN H Duncan, N A Hinton, J L Penner, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1996
Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitroA R Bender, H von Briesen, J Kreuter, et al.
Antiviral Research|January 1, 1996
Reduced sensitivity to saquinavir: an update on genotyping from phase I/II trialsH Jacobsen, M Haenggi, M Ott, et al.
Journal of Clinical Microbiology|January 1, 1979
O serotyping of Providencia stuartii isolates collected from twelve hospitalsJ L Penner, N A Hinton, I B Duncan, et al.
Antiviral Research|December 1, 1991
Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinaseJ C Craig, I B Duncan, D Hockley, et al.
The Journal of Infectious Diseases|June 1, 1996
In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequenciesH Jacobsen, M Hänggi, M Ott, et al.
Virology|January 10, 1995
Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959H Jacobsen, K Yasargil, D L Winslow, et al.
Journal of Medicinal Chemistry|February 1, 1989
Synthesis and antiviral activity of phosphonoacetic and phosphonoformic acid esters of 5-bromo-2'-deoxyuridine and related pyrimidine nucleosides and acyclonucleosidesR W Lambert, J A Martin, G J Thomas, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal (Canadian Dental Association)|December 1, 1982
The implications of viral hepatitis for the practice of dentistryJ H Main, I B Duncan, M M Fisher, et al.
Journal of Clinical Microbiology|December 1, 1978
Comparison of bacteriophage typing, serotyping, and biotyping as aids in epidemiological surveillance of Klebsiella infectionsR P Rennie, C E Nord, L Sjoberg, et al.
Journal of Clinical Microbiology|August 1, 1976
Preparation of typing antisera specific for O antigens of Pseudomonas aeruginosaN H Duncan, N A Hinton, J L Penner, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1996
Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitroA R Bender, H von Briesen, J Kreuter, et al.
Antiviral Research|January 1, 1996
Reduced sensitivity to saquinavir: an update on genotyping from phase I/II trialsH Jacobsen, M Haenggi, M Ott, et al.
Journal of Clinical Microbiology|January 1, 1979
O serotyping of Providencia stuartii isolates collected from twelve hospitalsJ L Penner, N A Hinton, I B Duncan, et al.
Antiviral Research|December 1, 1991
Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinaseJ C Craig, I B Duncan, D Hockley, et al.
The Journal of Infectious Diseases|June 1, 1996
In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequenciesH Jacobsen, M Hänggi, M Ott, et al.
Virology|January 10, 1995
Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959H Jacobsen, K Yasargil, D L Winslow, et al.
Journal of Medicinal Chemistry|February 1, 1989
Synthesis and antiviral activity of phosphonoacetic and phosphonoformic acid esters of 5-bromo-2'-deoxyuridine and related pyrimidine nucleosides and acyclonucleosidesR W Lambert, J A Martin, G J Thomas, et al.
Pageof 4